
Bio-Rad Laboratories, Inc. (BIO.B)
Last updated: 2026-11-07 01:51:20. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Bio-Rad Laboratories, Inc. (BIO.B) operates in the LABORATORY ANALYTICAL INSTRUMENTS sector and is listed on NYSE. The stock is currently priced at $381.71, with a market capitalization of $1.93B and a P/E ratio of 45.63. Over the past 52 weeks, its price has ranged from $244.54 to $386.63. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.93B | |
$374.93 | |
$818.60 | |
$47.00 | |
-- | |
8.00 | |
362.90 | |
45.63 | |
$386.63 | |
$244.54 | |
-- | |
-- |
Bio-Rad Laboratories, Inc. (BIO.B) Latest Closing Stock Price
Bio-Rad Laboratories, Inc. (BIO.B) last closed at $0.00 as of 2026-11-07 00:31:00, -- from the previous close of $0.00.
During the latest regular trading session, BIO.B traded between $47.00 and $818.60, with a volume of 8.00 shares. The closing price was near the lower end and near the upper end of its 52-week range.
Bio-Rad Laboratories, Inc. (BIO.B) 7-Day Stock Price Change
Over the past seven days, Bio-Rad Laboratories, Inc. (BIO.B) moved from $293.37 to $381.71, representing a gain of 30.11% ($88.34).
The stock traded between $293.37 and $386.63 during the period. The latest price is near the upper end of the 7-day range, indicating strong upward.
The average daily volume was 155.45 shares, down versus the previous seven-day period, indicating lower trading activity.
BIO.B 52-Week Price Position
Position in Range: 96.5%
BIO.B is currently trading at $381.71, placing it 96.5% of the way from its 52-week low of $244.54 to its 52-week high of $386.63. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Bio-Rad Laboratories, Inc. (BIO.B)?
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and sells products and solutions for the clinical diagnostics and life sciences markets. In clinical diagnostics (60% of sales), Bio-Rad sells test systems and specialized quality controls for clinical laboratories. In life sciences (40% of sales), it develops and manufactures instruments and reagents used in research, biopharmaceutical production, and food testing and has a leadership position in dPCR technology. The company is geographically diverse, with major markets in the Americas (about 40% of sales), Europe (about 30%), Asia (about 30%), and other. Bio-Rad owns approximately 33% of Sartorius, a lab and bioprocessing supplier that specializes in single-use technology used in biologics manufacturing.
Bio-Rad Laboratories, Inc. Information
| Industry | LABORATORY ANALYTICAL INSTRUMENTS |
| Employees | 7450 |
| Exchange | NYSE |
| Company Website |
How to Buy Bio-Rad Laboratories, Inc. (BIO.B) Stock on MEXC
Eligible investors can buy real shares of Bio-Rad Laboratories, Inc. (BIO.B) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Bio-Rad Laboratories, Inc. (BIO.B) stock price today?
2.Is BIO.B stock going up or down today?
3.What is BIO.B pre-market price?
4.What is BIO.B after-hours price?
5.Is BIO.B stock trading now?
6.Where does BIO.B sit relative to its 52-week high and low?
7.What sector is Bio-Rad Laboratories, Inc. in?
8.What is Bio-Rad Laboratories, Inc.'s market capitalization and where is it listed?
9.How is BIO.B valued in terms of P/E ratio and EPS?
10.Does Bio-Rad Laboratories, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
BIO.B Stock Calculator
Estimate the value between BIO.B shares and USD.
BIO.B Shares to USD
1.00 BIO.B shares = 381.712 USD
Calculations are estimates based on the latest available price and are for reference only.




